Skip to content
Research Article Open access CC BY 4.0

Viral Hepatitis Prevalence among Tribal and Non-Tribal Hospitalised Patients in Northeast India with a Note on its Prevalence before and During COVID-19

Harpreet Kaur, Biswajyoti Borkakoty, Kyrshanlang G Lynrah, Tapan Majumdar, Khumukcham Lokeshwar Singh, Basumoti Apum, Sangit Dutta, Lalrothuama, Temsu, Yogesh Verma, Subhash Medhi, Provash Chandra Sadhukhan, Vijay Kumar Karra, Vineet Kumar Kamal, Sriram Kannan, Amit Solanki, Mamta Singh, Anjan Jyoti Talukdar, Clarissa Jane Lyngdoh, Phukan AC, Nalini Sharma, Anup Kumar Das, Bhaskar Jyoti Saikia, Kanagasabai Kaliaperumal, Rajarshi Gupta, Lokhendra Singh, Ajanta Sharma, Tanma Saikia Das, Tanwir Alam, Kharibam Paikhomba Singh, Pradip Bhaumick, Jahar Lalbaidya, Star Pala, MD Ghaznavi Idris, Lalchhandama C, Lalawmpuia, Temsusashi, Amlan Gupta, Chhophellamtha S, Dipankar Biswas, Tali T, Tatak Obi, Moumita Majumdar, Wasifa Parween, Namita Deb, Neelanjana Sarmah, Simanta Kalita, Partha Pratim Das, Romi Khangembam, Asang Jamir, Lalmuansangi C, Roza Larilang Marbaniang

European Journal of Nutrition & Food Safety · pp. 317–335 · Published 4 Jul 2024

10.9734/ejnfs/2024/v16i71483

Abstract

Background: India is rich in tribal population including north-east India. This research of ours is based on viral hepatitis diagnosis (HBV, HCV, HDV. HAV. HEV) and prevalence in the eight north eastern states of India (namely Assam, Arunachal, Nagaland, Sikkim, Tripura, Meghalaya, Manipur, and Mizoram) that are in locations bordering other countries like Bangladesh, Bhutan and Nepal. The article intercompares the viral hepatitis prevalence pattern in tribal and non-tribal patients in the north eastern states of India as well as the overall prevalence pre-COVID-19 and during the COVID-19. Methodology: This cross-sectional study data on prevalence of viral hepatitis conducted in the 8 north eastern states of India between 2018-2022 has data. two years before the onset of COVID-19 (2018-2019) and 2 years during the COVID-19 (2020-2022). This manuscript presents retrospective comparison on viral hepatitis prevalence between the recruited viral hepatitis patients of tribal and non-tribal origin. This work also compares viral hepatitis prevalence pre-COVID19 and during COVID-19 with no planned work done on COVID-19 diagnostics.  Results: In this study, it was observed that younger adult tribal viral hepatitis patients in northeast India had higher prevalence of viral hepatitis than non-tribal patents of the same age group whereas older adult non-tribal patients had higher prevalence of viral hepatitis than tribal patients of the same age group. Certain tribes like Lushai of Mizoram had higher prevalence of HDV, HCV, HEV. Hepatitis B vaccination status was better in non-tribals than tribals in the recruited patients. Further in certain states like Manipur and Tripura exhibited significant difference in the diagnostic marker prevalence in hepatocellular carcinoma patients and liver cirrhosis patients before COVID and during COVID.  Conclusion: There were differences in the prevalence and risk factors of viral hepatitis between tribal and non-tribal patients of viral hepatitis in northeast India. Further COVID-19 did have influence on the viral hepatitis prevalence in northeast India.

COVID19 hepatitis HBV HCV HAV HEV tribal non-tribal Northeast India

References (39)

  1. 1 Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women [DOI]
  2. 2 Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens [DOI]
  3. 3 The Impact of Lockdown During the COVID-19 Outbreak on Dietary Habits in Various Population Groups: A Scoping Review [DOI]
  4. 4 Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo [DOI]
  5. 5 The global impact of the COVID-19 pandemic on the prevention, diagnosis and treatment of hepatitis B virus (HBV) infection [DOI]
  6. 6 Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey [DOI]
  7. 7 Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury [DOI]
  8. 8 Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection [DOI]
  9. 9 Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study [DOI]
  10. 10 Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality [DOI]
  11. 11 HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes [DOI]
  12. 12 Tribal Situation in North East India [DOI]
  13. 13 Seasonality of hepatitis: A review update [DOI]
  14. 14 Hepatitis Delta Virus (HDV) and Delta-Like Agents: Insights Into Their Origin [DOI]
  15. 15 Viruses in fermented foods: are they good or bad? Two sides of the same coin [DOI]
  16. 16 Interaction between hepatitis B virus and SARS-CoV-2 infections [DOI]
  17. 17 New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India [DOI]
  18. 18 Impact of COVID-19 pandemic and anti-pandemic measures on tuberculosis, viral hepatitis, HIV/AIDS and malaria–A systematic review [DOI]
  19. 19 Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study [DOI]
  20. 20 COVID-19 pandemic effects on the distribution of healthcare services in India: A systematic review [DOI]
  21. 21 COVID-19 and Coronaviral Hepatitis: Evidence of Collateral Damage [DOI]
  22. 22 Molecular epidemiology of hepatitis B virus in primitive tribes of Odisha, eastern India [DOI]
  23. 23 High Prevalence of Hepatitis C Virus Infection in Primitive Tribes of Eastern India and Associated Sociobehavioral Risks for Transmission: A Retrospective Analysis [DOI]
  24. 24 Hepatitis C Virus and its Genotypes in Chronic Liver Disease Patients from Meghalaya, Northeast India [DOI]
  25. 25 Nosocomial transmission of hepatitis E virus and development of chronic infection: The wider impact of COVID-19 [DOI]
  26. 26 Meat-based ethnic delicacies of Meghalaya state in Eastern Himalaya: preparation methods and significance [DOI]
  27. 27 Edible Insects as tribal food among the Rabhas of Assam [DOI]
  28. 28 AHP and GIS-based Risk Zonation of COVID-19 in North East India [DOI]
  29. 29 Suppression of hepatitis C virus replication during COVID‐19 infection [DOI]
  30. 30 Hyperbilirubinemia with mild COVID-19 patient [DOI]
  31. 31 The possibility of hepatitis C reactivation in COVID-19 patients treated with corticosteroids [DOI]
  32. 32 Impact of COVID-19 in North Eastern States of India
  33. 33 Prevalence and Risk Factors of Hepatitis C Virus in Irula Tribal Community, Tamilnadu, India [DOI]
  34. 34 Ethnic Food Habits of the Sumi Tribe, Nagaland, India [DOI]
  35. 35 Identity of Ao-Naga and Sümi-Naga Women as Gleaned from Folklores [DOI]
  36. 36 A Silent Outbreak of Hepatitis E Virus (HEV) Infection or False-Positive Reaction of Anti-HEV IgM after COVID-19 Vaccination? Epidemiological Investigation of an Outbreak in a Korean Factory Complex in 2022 [DOI]
  37. 37 Hepatitis D virus seroprevalence in HBsAg positive patients attending a tertiary care hospital in Northeast India [DOI]
  38. 38 Prevalence of Hepatitis A in and around the Aligarh region [DOI]
  39. 39 Hepatitis B in Trans-Himalayan Tribal Population: High Prevalence, High Pediatric Burden, Virologic Patterns, and Implications for Public Health Interventions [DOI]

Cited by 2

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

43

Page views

0

PDF downloads

41

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.